Summary
This prediction ended on 03.02.17 with a price of €103.45. The prediction closed with a disappointing performance of 20.07%. mohabbatein has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bayer AG | -2.060% | -2.060% | -48.756% | -46.887% |
iShares Core DAX® | -0.448% | 2.344% | 15.948% | 18.098% |
iShares Nasdaq 100 | 0.834% | 5.019% | 30.983% | 56.534% |
iShares Nikkei 225® | -0.479% | 0.550% | 9.206% | 5.013% |
iShares S&P 500 | -0.352% | 2.631% | 26.224% | 46.697% |
Comments by mohabbatein for this prediction
In the thread Bayer AG diskutieren
mohabbatein stimmt dem Crowdsentiment von 'Buy' nicht zu
mohabbatein stimmt am 30.05.2016 dem Buy-Crowdsentiment mit dem Kursziel 111.26€ nicht zu.
Sollte, wie allseits bereits gemunkelt wird, Bayer sein Gebot für Monsanto zeitnah von 122,- auf 130,- Dollar erhöhen, wird der Kurs nochmals in die Knie gehen.
SELL, bis mehr Klarheit vorhanden ist.